cGPT

current Good Tissue Practices as defined by the FDA, a subset of current Good Manufacturing Practices (cGMP)

First Cord Blood ‘Product’ Approved by FDA

November 11, 2011

HEMACORD(TM), a umbilical cord blood product, has been approved by the Food and Drug Administration for allogeneic hematopoietic stem cell transplantation, the first such approval of a stem cell product in the world. “The use of cord blood hematopoietic progenitor cell therapy offers potentially life-saving treatment options for patients with these types of disorders,” said [...]

Read the full article →

FamilyCord is the ONLY private Cord Blood Bank having both AABB Cord Blood and Hematopoietic Progenitor Cell Facility Accreditations

June 14, 2010

FamilyCord is accredited by the AABB as a Cord Blood Facility and a Hematopoietic Progenitor Cell (stem cells) Facility.  Since 1957, AABB has developed voluntary standards for blood bank blood component collection, processing and transfusion and assessed compliance with these standards — as well as with the Code of Federal Regulations and federal guidance documents [...]

Read the full article →

FDA Guidance to the Cord Blood Industry on CPD

April 21, 2010

In its latest guidance to the cord blood industry the FDA has recommended that cord blood banks  use only citrate-based anticoagulants (CPD) in their transport storage containers.  FamilyCord exclusively uses CPD in its state of the art collection kit. Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified [...]

Read the full article →

Factors Influencing Cord Blood Viability, a new study

April 14, 2010

Cord blood (CB) viability determines stem cell quality and varies with time and temperature of exposure prior to cryopreservation. In a recent study published in Transfusion – The Journal of AABB (Vol. 50, Issue 4) researchers from the Departments of Pathology and Pediatrics, St Louis University School of Medicine ; and St Louis Cord Blood Bank [...]

Read the full article →

Higher CD34+ Cells Collected Using Liquid CPD in Cord Blood Collection Kits

March 29, 2010

In a study presented at the 51st American Society of Hematology (ASH) Annual Meeting in December 2009, researchers found that cord blood collected with kits using Liquid CPD appeared to contain significantly more Nucleated and CD34+ cells than units collected with Dry Heparin. The number and potency of stem cells in collected cord blood after [...]

Read the full article →

FamilyCord Unveils Safer and More Effective Cord Blood Collection Kit

March 15, 2010

  March 2, 2010 – FamilyCord, a subsidiary of California Cryobank, is leading the charge in the private cord blood banking industry for safer, more effective collection kits. FamilyCord’s start-of-the-art collection kit is redefining the scientific standards for collection and transport employed by the cord blood banking industry. “Cord blood banking is an invaluable asset [...]

Read the full article →